LAUSR

References 1. Manning J, Zaidi I, Lon C, Rosas LA, Park J-K, Ponce A, et al. SARS-CoV-2 cross-reactivity in prepandemic serum from rural malaria-infected persons, Cambodia. Emerg Infect Dis. 2022;28:440–4. https://doi.org/10.3201/eid2802.211725 2. Sumner KM, Mangeni JN, Obala AA, Freedman E, Abel L, Meshnick SR, et al. Impact of asymptomatic Plasmodium falciparum infection on the risk of subsequent symptomatic malaria in a longitudinal cohort in Kenya. eLife. 2021;10:e68812. https://doi.org/10.7554/eLife.68812 3. Chia WN, Zhu F, Ong SWX, Young BE, Fong S-W, Le Bert N, et al. Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study. Lancet Microbe. 2021;2:e240–9. https://doi.org/10.1016/S2666-5247(21)00025-2 4. Tan CW, Chia WN, Qin X, Liu P, Chen MIC, Tiu C, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction. Nat Biotechnol. 2020;38:1073–8. https://doi.org/ 10.1038/s41587-020-0631-z 5. Addetia A, Crawford KHD, Dingens A, Zhu H, Roychoudhury P, Huang M-L, et al. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate. J Clin Microbiol. 2020;58:e02107–20. https://doi.org/10.1128/JCM.02107-20